Specialty Chemicals

Titan Biotech Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 54 filings·Updated 30 Sept 2026
Showing 10 of 54 filings.
30 Sept 20262 filings
Company UpdateAmendments to Memorandum & Articles of Association

Alteration of the Clause 5 i.e. Capital Clause of the Memorandum of Association (MOA) of the Company

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 16:24View Source
AGM/EGMAGM

Titan Biotech Ltd's 34th AGM via VC/OAVM approves financials, dividend, capital actions and director appointments

AGM Details

  • Date/time: 29 Sep 2026, 3:00 PM IST; mode: VC/OAVM.
  • Record date: 22 Sep 2026.
  • Shareholders on record: 19,666; meeting attended via VC/OAVM by promoters/public.

Key Resolutions

  • Adoption of audited financial statements for year ended 31 Mar 2026 and reports.
  • Dividend on equity shares for year ended 31 Mar 2026.
  • Reappointment of Supriya Singla as Director, retire-by-rotation.
  • Reappointment of Shivom Singla as Director, retire-by-rotation.
  • Reappointment of Rohit J as Independent Director for 5 years from 30 Sep 2026.
  • Increase in authorized share capital and alteration of MOA/Articles.
  • Issue of bonus equity shares.
  • Ratification of remuneration of Cost Auditor for FY 2026-27.
  • Mortgage of company property under Section 180(1)(a) to secure borrowings.
  • Authority to borrow funds and create charges.

Voting Results

  • All resolutions passed; minor opposing votes observed on some items.
  • No resolution failed; overall majority in favour.

Dividend

  • Dividend declared/approved on equity shares; per-share amount not disclosed.

Director Changes

  • Supriya Singla reappointed as Director (retire-by-rotation).
  • Shivom Singla reappointed as Director (retire-by-rotation).
  • Rohit J reappointed as Independent Director for 5-year term.

Auditors

  • Remuneration for Cost Auditor for FY 2026-27 ratified.

Material Related Party Transactions

  • No material related party transactions disclosed or approved.

Other Material Approvals

  • Bonus issue approved; authorized capital increased; borrowing-related approvals.
Filed 15:43View Source
29 Sept 20261 filing
AGM/EGMAGM

Titan Biotech's 34th AGM held via VC; ordinary business discussed financials and dividend, with multiple special resolutions

AGM Details

  • Date: 29 September 2026
  • Time: 3:00 PM IST
  • Mode: VC/OAVM

Key Resolutions

  • Ordinary: Adopt audited financial statements (standalone and consolidated) for FY 2026.
  • Ordinary: Dividend on equity shares.
  • Ordinary: Re-appointment of Supriya Singla as director liable to retire by rotation.
  • Ordinary: Re-appointment of Shivom Singla as director liable to retire by rotation.
  • Special: Increase in authorised share capital and alteration of MOA.
  • Special: Issuance of bonus equity shares to members.
  • Special: Authorization for loans and borrowings.
  • Special: Ratification of remuneration of Cost Auditor for 2026-27.
  • Special: Mortgage of company property for borrowing; permission under Section 180(1)(a).
  • Special: Re-appointment of Rohit Jain as Independent Director for second five-year term from 30 Sep 2026.

Voting Results

  • Adoption of financial statements: results not disclosed.
  • Dividend declaration: results not disclosed.
  • Re-appointment of Supriya Singla: results not disclosed.
  • Re-appointment of Shivom Singla: results not disclosed.
  • Increase in authorised capital: results not disclosed.
  • Issuance of bonus shares: results not disclosed.
  • Authorization for loans: results not disclosed.
  • Remuneration of Cost Auditor: results not disclosed.
  • Mortgage for borrowings: results not disclosed.
  • Rohit Jain Independent Director: results not disclosed.

Dividend Status

  • Dividend declaration status not disclosed; amount per share not disclosed.

Director Changes

  • Re-appointment of Supriya Singla as director liable to retire by rotation.
  • Re-appointment of Shivom Singla as director liable to retire by rotation.
  • Re-appointment of Rohit Jain as Independent Director for second five-year term from 30 Sep 2026.

Auditors & Cost Auditor

  • Statutory auditors attended via VC; no changes in appointment.
  • Cost Auditor remuneration ratified for 2026-27.
Filed 18:43View Source
24 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Titan Biotech Limited — Trading window closed from October 01, 2026 till the expiry of 48 hours after the declaration of Unaudited financial results (standalone & consolidated) for quarter and half year ending September 30, 2026

Titan Biotech Limited — Trading window closed from October 01, 2026 till the expiry of 48 hours after the declaration of Unaudited financial results (standalone & consolidated) for quarter and half year ending September 30, 2026

Filed 16:08View Source
10 Sept 20261 filing
Company UpdateNewspaper Publication

Notice of Loss of Share Certificate-Disclosure under Regulation 30 of SEBI ( Listing Obligation and Disclosure Requirements) Regulations, 2015

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 12:52View Source
7 Sept 20261 filing
Company UpdateNewspaper Publication

Newspaper Publication regarding Notice of 34th Annual General Meeting, E-Voting and other related information

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 10:34View Source
4 Sept 20261 filing
Company UpdateNewspaper Publication

Newspaper advertisement regarding 34th Annual General Meeting of Titan Biotech Limited through VC/OAVM

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 11:20View Source
3 Sept 20263 filings
Corp. ActionRecord Date

Titan Biotech fixes record date for final dividend of Rs 0.50 per share, subject to AGM

Record Date and Dividend Details

  • Final dividend of Rs 0.50 per equity share for FY 2025-26, subject to AGM approval.
  • Record date fixed as Tuesday, 22 September 2026.
  • Dividend payment will be made after the AGM, subject to tax deduction at source.
  • Share type: equity shares; subject to shareholder approval at the 34th AGM.
Filed 12:42View Source
AGM/EGMAGM

Titan Biotech sets Sep 29, 2026 AGM via VC with Sep 22 record date and Sep 23-29 book closure

AGM schedule and record closure

  • 34th AGM to be held Sep 29, 2026 at 03:00 PM IST via Video Conferencing.
  • Register of Members and transfer books closed Sep 23-29, 2026 inclusive.
  • Record Date fixed Sep 22, 2026 for entitlement to final dividend.

E-voting window

  • Cut-off date for e-voting: Sep 22, 2026.
  • Remote e-voting starts Sep 26, 2026 at 10:00 AM.
  • Remote e-voting ends Sep 28, 2026 at 5:00 PM.

Dividend declaration

  • Final dividend for year ended Mar 31, 2026 will be paid.
Filed 12:32View Source
Corp. ActionBonus

Titan Biotech approves 1:4 equity bonus issued from reserves; increases authorised capital

Bonus details

  • Equity shares; face value Rs 2 per share.
  • Bonus ratio 1:4 (one new share for four existing).
  • Source: securities premium, retained earnings, or free reserves.
  • Total bonus shares: 1,03,29,625.
  • Authorised capital: pre 5,00,00,000; post 5,20,00,000; subject to shareholder approval.
  • Paid-up capital: pre 4,13,18,500; post 5,16,48,125.
  • Subscribed capital: pre 4,13,18,500; post 5,16,48,125.
  • Record date for eligibility to be announced later.
  • Credit/distribution will occur within 2 months of board approval, by 03 Nov 2026.
  • Free reserves for capitalization: Rs 16,257.78 Lakhs (as on 31 Mar 2026); audited.
  • Subject to AGM approval; MOA amendment and capital increase.
Filed 12:21View Source
Showing 10 of 54 filings